VANCOUVER, Canada — Canadian life sciences company, Ondine Biomedical, has concluded the first development phase of a new food-safe photodisinfection technology for Canada’s meat packing industry. The findings which will be presented at a webinar on Wednesday 12 April, 2023 will report on identifying and screening potential food-safe photosensitizers for efficacy against bacterial biofilms common in food processing.
In December 2022 Ondine was awarded nearly $735,000 to undertake this research, which was funded in part by the Government of Canada under the Canadian Agricultural Partnership’s AgriScience Program, a federal, provincial, territorial initiative. The AgriScience Program aims to accelerate the pace of innovation by providing funding and support for pre-commercial science activities and cutting-edge research that benefits consumers and the agriculture and agri-food sector.
The food-processing industry has a need for the development of technologies to reduce the incidence of food-borne pathogens including bacteria, fungi, viruses, and protozoa. Eradicating these invasive microbes will help protect the $9.4 billion (2021) Canadian meat export industry, as well enhance the lives and welfare of consumers by reducing the incidence of food-borne illnesses.
Ondine is the world leader in the development of photodisinfection technology, and has already proven the safety and effectiveness of the technology at hospitals across Canada where it is used to decolonize the nose prior to surgery to prevent surgical site infections ( SSIs) – Vancouver General Hospital has reported reducing SSIs in patients undergoing major surgery by over 50%.
Webinar: “Photodisinfection for Food Safety”
Timing: Wednesday 12 April, 2023 at 12:00pm EST / 5:00pm BST
- Dr. Richard Rusk (DVM, MD, CCFP, MPH, DipZBPV, FRSPH), Prevention Medicine Specialist and former Manitoba Medical Officer of Health
- Dr. Nicolas Loebel, Ondine Biomedical President and Chief Technology Officer
- Dr. Joseph Ross, Senior Scientist at Chinook Contract Research
About Ondine Biomedical Inc.
Ondine Biomedical Inc. is a Canadian headquartered company innovating in the field of photodisinfection therapies. Ondine has a pipeline of investigational products, based on its proprietary photodisinfection platform, in various stages of development. Products beyond nasal photodisinfection include therapies for a variety of medical indications such as chronic sinusitis, ventilator-associated pneumonia, burns, and other indications.
Ondine Biomedical Inc.
Angelika Vance, Corporate Communications
+001 (604) 838 2702
Vane Percy & Roberts (Media Contact)
Simon Vane Percy, Amanda Bernard
+44 (0)77 1000 5910